The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2019

Filed:

Feb. 15, 2017
Applicant:

Nordic Rebalance A/s, Hillerød, DK;

Inventor:

Hans Israelsen, Allerod, DK;

Assignee:

NORDIC REBALANCE A/S, Hillerød, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/74 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 36/899 (2006.01); A61K 31/685 (2006.01); A61K 45/06 (2006.01); A61K 35/744 (2015.01); A61K 35/66 (2015.01); A61K 35/742 (2015.01); A61K 31/196 (2006.01); A23L 7/152 (2016.01); A23L 33/135 (2016.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/899 (2013.01); A23L 7/152 (2016.08); A23L 33/135 (2016.08); A61K 31/196 (2013.01); A61K 31/685 (2013.01); A61K 35/66 (2013.01); A61K 35/74 (2013.01); A61K 35/742 (2013.01); A61K 35/744 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A23V 2200/3204 (2013.01); A61K 2035/115 (2013.01); Y02A 90/22 (2018.01); Y02A 90/26 (2018.01);
Abstract

The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.


Find Patent Forward Citations

Loading…